It has been demonstrated that MSC may differentiate to hepatocyte‐like cells, which after syngeneic transplantation into a host liver persist in the parenchyma. Evidence emerges that MSC display tolerogenic attributes. Therefore, we investigated acceptance of allogeneic MSC transplants in rat models of liver regeneration and cirrhosis.MSC were isolated from adipose tissue of CD26 wildtype DA rats and cells either undifferentiated or after hepatocyte differentiation transplanted into the livers of CD26‐deficient Fischer rats via portal vein. After 10 weeks, small clusters of allogeneic donor cells were visible in the host parenchyma. Compared with undifferentiated cells, clusters were seemingly larger when differentiated cells were used but were by far smaller as compared to the transplantation of syngeneic MSC. When cells were applied systemically via tail vein injection, small clusters of allogeneic donor‐derived cells were visible in the host liver parenchyma after 5 days in animals challenged with partial hepatectomy and with CCl4‐induced liver cirrhosis. This demonstrates that allogeneic MSC home to the liver after acute and chronic liver injury. They integrate into the host liver indicating their acceptance by the host immune system at least in the short term range. This offers the opportunity to use allogeneic MSC for the therapy of liver diseases avoiding immune suppression.
Read full abstract